bingoshowdown| [Interpretation of Tuifeng] The chairman of Yangpu Medical lifted the detention and was previously investigated for suspected violations of discipline and law.

If you want to speculate in the stock market, you can see the research report of Jin Kirin analysts.BingoshowdownAuthoritative, professional, timely, comprehensive, to help you tap the potential theme opportunities!

Bubble Finance learned that on the evening of May 12, Yangpu Medical (300030)Bingoshowdown.SZ) notice that on 11 May, the company received a notice from Deng Guanhua's family that it had received a notice of removal of the lien issued by the Guangdong Provincial Supervisory Commission, which had lifted the detention measures against Mr. Deng Guanhua. At present, the production, operation and management of the company is normal, and Deng Guanhua has been able to normally perform the duties of the company's legal representative, chairman and general manager. Jiang Guangcheng, director and deputy general manager of the company, will no longer perform the duties of the company's legal representative, chairman, general manager and relevant committee members of the board of directors.

The main business of Yangpu Medical is precision medical, intelligent medical and laboratory services. The company's main products include vacuum vascular collection, microbial transport system, instruments, reagents, software products and services and inspection services.

Prior to April 7, Yangpu Medical issued an announcement that Deng Guanhua, chairman and general manager of the company, was placed on file for investigation and lien on suspicion of violating discipline and law.

Lien is the most stringent investigation measure stipulated in the Supervision Law. Article 22 of the Supervision Law provides for situations in which the person under investigation "may be detained in a specific place", including those involving serious and complex cases; those who may escape or commit suicide; those who may collude to confess or falsify, conceal or destroy evidence; other acts that may hinder the investigation. In addition, the supervisory organ may take lien measures in accordance with the provisions of the preceding paragraph for persons suspected of bribery or joint job-related crimes.

Deng Guanhua graduated from Wuhan University with a doctorate and postgraduate degree. From June 1988 to December 1989, he taught in the Department of Chemistry, Wuhan University. From December 1991 to January 1995, he served as the director of the Institute of Chemical Chemistry of Wuhan University. Participated in the founding of Guangzhou Yangpu Medical products Co., Ltd in 1996, served as the legal representative of Yangpu Medical products from January 1999 to October 2007, served as General Manager of Yangpu Medical products from November 2003 to October 2007, and has been the Chairman and General Manager of Yangpu Medical Technology Co., Ltd since October 2007. He is currently the chairman and general manager of the fifth board of directors of Yangpu Medical Technology Co., Ltd.

Yangpu Medical has lost money for two years in a row.

In 2021 and 2022, Yangpu Medical's operating income was 800 million yuan and 711 million yuan respectively, up-12.99 percent and-11.14 percent respectively over the same period last year; and net profit was 18.5685 million yuan and-198 million yuan respectively, up-88.57 percent and-1167.94 percent respectively over the same period last year.

In 2023, the company had a revenue of 645 million yuan and a loss of 63.2038 million yuan.

This article was first published in the bubble financial tuyere interpretation topic, if there is a reprint, please indicate the source.